Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Shoptaw

Showing results (251-260 of 260) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 260 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US CitiesXiao Zang, Cassandra Mah, Amanda My Linh Quan, et al.
AIDS Research and Human Retroviruses|April 7, 2017
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United StatesIris Chen, Yinfeng Zhang, Vanessa Cummings, et al.
Journal of the International AIDS Society|January 9, 2020
Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?Dvora L Joseph Davey, Jillian Pintye, Jared M Baeten, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programsSusan Tross, Aimee N C Campbell, Donald A Calsyn, et al.
The Lancet. HIV|August 9, 2020
Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science frameworkJillian Pintye, Dvora L Joseph Davey, Anjuli D Wagner, et al.
Alcoholism, Clinical and Experimental Research|November 8, 2018
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and SafetyDaniel E Falk, Megan L Ryan, Joanne B Fertig, et al.
The Journal of Infectious Diseases|October 8, 2022
Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation StudyChelsea L Shover, Allison Rosen, José Mata, et al.
Trials|June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina TrialRebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
The New England Journal of Medicine|February 18, 2026
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence ChallengesAadia I Rana, Lu Zheng, Jose Castillo-Mancilla, et al.
JAMA Psychiatry|April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.
Pageof 26

Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US CitiesXiao Zang, Cassandra Mah, Amanda My Linh Quan, et al.
AIDS Research and Human Retroviruses|April 7, 2017
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United StatesIris Chen, Yinfeng Zhang, Vanessa Cummings, et al.
Journal of the International AIDS Society|January 9, 2020
Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?Dvora L Joseph Davey, Jillian Pintye, Jared M Baeten, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programsSusan Tross, Aimee N C Campbell, Donald A Calsyn, et al.
The Lancet. HIV|August 9, 2020
Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science frameworkJillian Pintye, Dvora L Joseph Davey, Anjuli D Wagner, et al.
Alcoholism, Clinical and Experimental Research|November 8, 2018
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and SafetyDaniel E Falk, Megan L Ryan, Joanne B Fertig, et al.
The Journal of Infectious Diseases|October 8, 2022
Engaging Same-Day Peer Ambassadors to Increase Coronavirus Disease 2019 Vaccination Among People Experiencing Unsheltered Homelessness in Los Angeles County: A Hybrid Feasibility-Evaluation StudyChelsea L Shover, Allison Rosen, José Mata, et al.
Trials|June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina TrialRebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
The New England Journal of Medicine|February 18, 2026
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence ChallengesAadia I Rana, Lu Zheng, Jose Castillo-Mancilla, et al.
JAMA Psychiatry|April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.
Pageof 26